March 2006 — Taxotere was approved for use in combination with cisplatin and fluorouracil for patients being treated for advanced gastric adenocarcinoma, including adenocarcinoma of the gastroesophageal junction, who had not received prior chemotherapy.
Reference: “Taxotere Wins FDA Approval for Advanced Gastric Cancer.” Cancer Network, www.cancernetwork.com/view/taxotere-wins-fda-approval-advanced-gastric-cancer